Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Medical University of South Carolina at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Medical University of South Carolina brings 2 presentations to SITC 2026 in Phoenix. Its program centres on testing immunotherapy in human tumor tissue outside the body and on improving treatment for solid tumors. A concrete result is updated survival data for nogapendekin alfa inbakicept, an IL-15 receptor booster, in solid tumors after checkpoint inhibitors have stopped working.

Organization

SITC 2026 Attendance

Medical University of South Carolina

Charleston, SC

musc.edu

Universities & research institutes

Academic health sciences university in Charleston, home of the Hollings Cancer Center.

Session

Fri Nov 6
1:45pm–3:25pm

Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip

301A

Models & tech

2:00pm–2:15pmPatient-Derived Brain Tumor Organoids to Model and Overcome Myeloid ImmunosuppressionCase Western Reserve University
2:15pm–2:30pmPersonalizing Cancer Immunotherapy Using Patient-Derived Tumor ModelsNetherlands Cancer Institute
2:30pm–2:45pmDynamic Immune Profiling Using Human Ex Vivo Tumor ModelsDana-Farber Cancer Institute
2:45pm–3:00pmFrom Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety AssessmentU.S. Food and Drug Administration
3:00pm–3:10pmGARP–TGF-β1 Blockade with Livmoniplimab Reprograms Spatial Tumor Niches and Enhances PD-1 Inhibition in Human Tumor ExplantsAbbVie
3:10pm–3:20pmA patient-specific multicellular glioblastoma model captures neuroimmune crosstalk and immunotherapy resistanceTissueGenix